Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Is gout a risk equivalent to diabetes for stroke and myocardial infarction? A retrospective claims database study.

Singh JA, Ramachandaran R, Yu S, Yang S, Xie F, Yun H, Zhang J, Curtis JR.

Arthritis Res Ther. 2017 Oct 17;19(1):228. doi: 10.1186/s13075-017-1427-5.

2.

Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes.

Singh JA, Ramachandaran R, Yu S, Curtis JR.

BMC Cardiovasc Disord. 2017 Mar 14;17(1):76. doi: 10.1186/s12872-017-0513-6.

3.

Characteristics of new depression diagnoses in patients with and without prior chronic opioid use.

Scherrer JF, Salas J, Schneider FD, Bucholz KK, Sullivan MD, Copeland LA, Ahmedani BK, Burroughs T, Lustman PJ.

J Affect Disord. 2017 Mar 1;210:125-129. doi: 10.1016/j.jad.2016.12.027. Epub 2016 Dec 21.

PMID:
28033519
4.

A real-world study of treatment patterns and outcomes in US managed-care patients with type 2 Diabetes initiating injectable therapies.

Wei W, Buysman E, Grabner M, Xie L, Brekke L, Ke X, Chu JW, Levin PA.

Diabetes Obes Metab. 2017 Mar;19(3):375-386. doi: 10.1111/dom.12828. Epub 2017 Jan 20.

5.

Measuring Preventive Care Delivery: Comparing Rates Across Three Data Sources.

Bailey SR, Heintzman JD, Marino M, Hoopes MJ, Hatch BA, Gold R, Cowburn SC, Nelson CA, Angier HE, DeVoe JE.

Am J Prev Med. 2016 Nov;51(5):752-761. doi: 10.1016/j.amepre.2016.07.004. Epub 2016 Aug 10.

6.

The influence of prescription opioid use duration and dose on development of treatment resistant depression.

Scherrer JF, Salas J, Sullivan MD, Schneider FD, Bucholz KK, Burroughs T, Copeland L, Ahmedani B, Lustman PJ.

Prev Med. 2016 Oct;91:110-116. doi: 10.1016/j.ypmed.2016.08.003. Epub 2016 Aug 3.

7.

New depression diagnosis following prescription of codeine, hydrocodone or oxycodone.

Scherrer JF, Salas J, Bucholz KK, Schneider FD, Burroughs T, Copeland LA, Sullivan MD, Lustman PJ.

Pharmacoepidemiol Drug Saf. 2016 May;25(5):560-8. doi: 10.1002/pds.3999. Epub 2016 Mar 22.

8.

Depression Quality of Care: Measuring Quality over Time Using VA Electronic Medical Record Data.

Farmer MM, Rubenstein LV, Sherbourne CD, Huynh A, Chu K, Lam CA, Fickel JJ, Lee ML, Metzger ME, Verchinina L, Post EP, Chaney EF.

J Gen Intern Med. 2016 Apr;31 Suppl 1:36-45. doi: 10.1007/s11606-015-3563-4.

9.

Increased Risk of Depression Recurrence After Initiation of Prescription Opioids in Noncancer Pain Patients.

Scherrer JF, Salas J, Copeland LA, Stock EM, Schneider FD, Sullivan M, Bucholz KK, Burroughs T, Lustman PJ.

J Pain. 2016 Apr;17(4):473-82. doi: 10.1016/j.jpain.2015.12.012. Epub 2016 Feb 13.

10.

The Method for Performance Measurement Matters: Diabetes Care Quality as Measured by Administrative Claims and Institutional Registry.

McCoy RG, Tulledge-Scheitel SM, Naessens JM, Glasgow AE, Stroebel RJ, Crane SJ, Bunkers KS, Shah ND.

Health Serv Res. 2016 Dec;51(6):2206-2220. doi: 10.1111/1475-6773.12453. Epub 2016 Feb 4.

PMID:
26846443
11.

Prescription Opioid Duration, Dose, and Increased Risk of Depression in 3 Large Patient Populations.

Scherrer JF, Salas J, Copeland LA, Stock EM, Ahmedani BK, Sullivan MD, Burroughs T, Schneider FD, Bucholz KK, Lustman PJ.

Ann Fam Med. 2016 Jan-Feb;14(1):54-62. doi: 10.1370/afm.1885.

12.

Linking individual medicare health claims data with work-life claims and other administrative data.

Mokyr Horner E, Cullen MR.

BMC Public Health. 2015 Sep 30;15:995. doi: 10.1186/s12889-015-2329-6.

13.

Early-Life State-of-Residence Characteristics and Later Life Hypertension, Diabetes, and Ischemic Heart Disease.

Rehkopf DH, Eisen EA, Modrek S, Mokyr Horner E, Goldstein B, Costello S, Cantley LF, Slade MD, Cullen MR.

Am J Public Health. 2015 Aug;105(8):1689-95. doi: 10.2105/AJPH.2014.302547. Epub 2015 Jun 11.

14.

Using "big data" to capture overall health status: properties and predictive value of a claims-based health risk score.

Hamad R, Modrek S, Kubo J, Goldstein BA, Cullen MR.

PLoS One. 2015 May 7;10(5):e0126054. doi: 10.1371/journal.pone.0126054. eCollection 2015.

15.

Validation of Diagnostic Groups Based on Health Care Utilization Data Should Adjust for Sampling Strategy.

Cadieux G, Tamblyn R, Buckeridge DL, Dendukuri N.

Med Care. 2017 Aug;55(8):e59-e67. doi: 10.1097/MLR.0000000000000324.

16.

Clinical outcomes and health care costs combining metformin with sitagliptin or sulphonylureas or thiazolidinediones in uncontrolled type 2 diabetes patients.

Degli Esposti L, Saragoni S, Buda S, Degli Esposti E.

Clinicoecon Outcomes Res. 2014 Oct 21;6:463-72. doi: 10.2147/CEOR.S63666. eCollection 2014.

17.

Agreement of Medicaid claims and electronic health records for assessing preventive care quality among adults.

Heintzman J, Bailey SR, Hoopes MJ, Le T, Gold R, O'Malley JP, Cowburn S, Marino M, Krist A, DeVoe JE.

J Am Med Inform Assoc. 2014 Jul-Aug;21(4):720-4. doi: 10.1136/amiajnl-2013-002333. Epub 2014 Feb 7.

18.

Impact of a high-deductible health plan on outpatient visits and associated diagnostic tests.

Reddy SR, Ross-Degnan D, Zaslavsky AM, Soumerai SB, Wharam JF.

Med Care. 2014 Jan;52(1):86-92. doi: 10.1097/MLR.0000000000000008.

19.

Outcomes among chronically ill adults in a medical home prototype.

Liss DT, Fishman PA, Rutter CM, Grembowski D, Ross TR, Johnson EA, Reid RJ.

Am J Manag Care. 2013 Oct 1;19(10):e348-58.

20.

The INITIATOR study: pilot data on real-world clinical and economic outcomes in US patients with type 2 diabetes initiating injectable therapy.

Thayer S, Wei W, Buysman E, Brekke L, Crown W, Grabner M, Raparla S, Quimbo R, Cziraky MJ, Hu W, Cuddihy R.

Adv Ther. 2013 Dec;30(12):1128-40. doi: 10.1007/s12325-013-0074-8. Epub 2013 Nov 30.

Supplemental Content

Support Center